Which hedge funds own AVBP? ARRIVENT BIOPHARMA INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
34 tracked hedge funds disclosed a position in AVBP (ARRIVENT BIOPHARMA INC) in their Q2 2026 13F filings, worth $837.2m in total. The largest holder by portfolio weight is Hhlr Advisors, Ltd. at 16.4% of its book. 10 opened a new position this quarter: KVP Capital Advisors, LP, Morgan Creek Capital Management, LLC, Fox Run Management, L.L.C., Soleus Capital Management, L.P.. 7 exited: Polymer Capital Management (HK) LTD, Jones Hill Capital LP, IvyRock Asset Management (HK) Ltd.
34
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
10
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
7
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$10.7m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$10.4m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$837m
Combined value
Sum of the holders' reported positions in the security.
2.7%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.